Robert M Kunemund
Examiner (ID: 4089)
Most Active Art Unit | 1714 |
Art Unit(s) | 1107, 1765, 1714, 1792, 1722, 1109, 1103, 1763 |
Total Applications | 3442 |
Issued Applications | 2671 |
Pending Applications | 149 |
Abandoned Applications | 593 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15769401
[patent_doc_number] => 20200115718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => METHODS, SYSTEMS, AND COMPOSITIONS FOR LEGUME-BASED PRODUCTION OF THERAPEUTIC PROTEINS AND THERAPEUTIC MEDICAL MATERIALS
[patent_app_type] => utility
[patent_app_number] => 16/623187
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16623187
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/623187 | METHODS, SYSTEMS, AND COMPOSITIONS FOR LEGUME-BASED PRODUCTION OF THERAPEUTIC PROTEINS AND THERAPEUTIC MEDICAL MATERIALS | Jun 17, 2018 | Abandoned |
Array
(
[id] => 13618731
[patent_doc_number] => 20180360917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => SINCALIDE FORMULATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/009945
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16009945
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/009945 | SINCALIDE FORMULATIONS AND METHODS OF USE | Jun 14, 2018 | Abandoned |
Array
(
[id] => 16466778
[patent_doc_number] => 20200368315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => ANTIMICROBIAL PEPTIDES AND ADMIXTURES THEREOF SHOWING ANTIMICROBIAL ACTIVITY AGAINST GRAM-NEGATIVE PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 16/622533
[patent_app_country] => US
[patent_app_date] => 2018-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622533
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622533 | ANTIMICROBIAL PEPTIDES AND ADMIXTURES THEREOF SHOWING ANTIMICROBIAL ACTIVITY AGAINST GRAM-NEGATIVE PATHOGENS | Jun 12, 2018 | Abandoned |
Array
(
[id] => 16475038
[patent_doc_number] => 10849958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Knee pain evaluation and management via WOMAC and KOOS systems
[patent_app_type] => utility
[patent_app_number] => 16/006589
[patent_app_country] => US
[patent_app_date] => 2018-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11308
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16006589
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/006589 | Knee pain evaluation and management via WOMAC and KOOS systems | Jun 11, 2018 | Issued |
Array
(
[id] => 15324127
[patent_doc_number] => 20200002393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => METHOD OF MANAGING JOINT PAIN
[patent_app_type] => utility
[patent_app_number] => 16/006475
[patent_app_country] => US
[patent_app_date] => 2018-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16006475
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/006475 | Method of managing joint pain | Jun 11, 2018 | Issued |
Array
(
[id] => 15290735
[patent_doc_number] => 20190388503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => FORMULATION, DOSAGE FORM AND METHOD OF REDUCING KNEE PAIN
[patent_app_type] => utility
[patent_app_number] => 16/006638
[patent_app_country] => US
[patent_app_date] => 2018-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16006638
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/006638 | Formulation, dosage form and method of reducing knee pain | Jun 11, 2018 | Issued |
Array
(
[id] => 13574931
[patent_doc_number] => 20180339014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => PEPTIDOMIMETIC MACROCYCLES
[patent_app_type] => utility
[patent_app_number] => 16/002977
[patent_app_country] => US
[patent_app_date] => 2018-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16002977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/002977 | PEPTIDOMIMETIC MACROCYCLES | Jun 6, 2018 | Abandoned |
Array
(
[id] => 17587687
[patent_doc_number] => 11325943
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Crystalline salt forms of SBT-20
[patent_app_type] => utility
[patent_app_number] => 16/492521
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19633
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492521
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492521 | Crystalline salt forms of SBT-20 | May 31, 2018 | Issued |
Array
(
[id] => 16686753
[patent_doc_number] => 20210069228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => PHARMACEUTICAL OR COSMETIC COMPOSITION FOR PREVENTING OR TREATING HAIR LOSS OR PROMOTING HAIR GROWTH
[patent_app_type] => utility
[patent_app_number] => 16/763392
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16763392
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/763392 | Pharmaceutical or cosmetic composition for preventing or treating hair loss or promoting hair growth | May 29, 2018 | Issued |
Array
(
[id] => 13586499
[patent_doc_number] => 20180344798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => TOPICALLY ACTIVE PEPTIDES FOR TREATING COSMETIC AND DERMATOLOGICAL CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 15/989823
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989823
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/989823 | TOPICALLY ACTIVE PEPTIDES FOR TREATING COSMETIC AND DERMATOLOGICAL CONDITIONS | May 24, 2018 | Abandoned |
Array
(
[id] => 15882843
[patent_doc_number] => 10647753
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Insulin analogs and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/990495
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9985
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15990495
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/990495 | Insulin analogs and use thereof | May 24, 2018 | Issued |
Array
(
[id] => 16483960
[patent_doc_number] => 20200377561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => ANTIMICROBIAL PEPTIDES AND METHODS OF TREATING GRAM-NEGATIVE PATHOGEN INFECTIONS: POLAR AND NON-POLAR FACE ANALOGS
[patent_app_type] => utility
[patent_app_number] => 16/616372
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13306
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616372
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616372 | ANTIMICROBIAL PEPTIDES AND METHODS OF TREATING GRAM-NEGATIVE PATHOGEN INFECTIONS: POLAR AND NON-POLAR FACE ANALOGS | May 22, 2018 | Abandoned |
Array
(
[id] => 16861735
[patent_doc_number] => 11020457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Compositions and methods for protecting the kidney from ischemia reperfusion injury
[patent_app_type] => utility
[patent_app_number] => 15/981954
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 66
[patent_no_of_words] => 30640
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15981954
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/981954 | Compositions and methods for protecting the kidney from ischemia reperfusion injury | May 16, 2018 | Issued |
Array
(
[id] => 13837383
[patent_doc_number] => 20190022176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => USE OF MK2 INHIBITOR PEPTIDE-CONTAINING COMPOSITIONS FOR TREATING NON-SMALL CELL LUNG CANCER WITH SAME
[patent_app_type] => utility
[patent_app_number] => 15/977110
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15977110
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/977110 | USE OF MK2 INHIBITOR PEPTIDE-CONTAINING COMPOSITIONS FOR TREATING NON-SMALL CELL LUNG CANCER WITH SAME | May 10, 2018 | Abandoned |
Array
(
[id] => 17648563
[patent_doc_number] => 11351266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Conjugate of isotretinoin and peptide
[patent_app_type] => utility
[patent_app_number] => 16/612125
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 7211
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612125
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612125 | Conjugate of isotretinoin and peptide | May 10, 2018 | Issued |
Array
(
[id] => 15963095
[patent_doc_number] => 20200165299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 16/611067
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611067
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/611067 | Compositions and methods for treating pulmonary hypertension | May 10, 2018 | Issued |
Array
(
[id] => 19165864
[patent_doc_number] => 11981752
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Tumor associated monocyte/macrophage binding peptide and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/607043
[patent_app_country] => US
[patent_app_date] => 2018-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 55823
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607043
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/607043 | Tumor associated monocyte/macrophage binding peptide and methods of use thereof | Apr 30, 2018 | Issued |
Array
(
[id] => 16479359
[patent_doc_number] => 10854312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Selective peptide antagonists
[patent_app_type] => utility
[patent_app_number] => 15/964717
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 34
[patent_no_of_words] => 23234
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15964717
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/964717 | Selective peptide antagonists | Apr 26, 2018 | Issued |
Array
(
[id] => 13383649
[patent_doc_number] => 20180243366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => DRUG CONTAINING RECOMBINANT MISTLETOE LECTINS FOR TREATING MALIGNANT MELANOMA
[patent_app_type] => utility
[patent_app_number] => 15/963905
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15963905
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/963905 | DRUG CONTAINING RECOMBINANT MISTLETOE LECTINS FOR TREATING MALIGNANT MELANOMA | Apr 25, 2018 | Abandoned |
Array
(
[id] => 16383187
[patent_doc_number] => 10808009
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Peptide conjugates
[patent_app_type] => utility
[patent_app_number] => 15/957806
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 44
[patent_no_of_words] => 36088
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15957806
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/957806 | Peptide conjugates | Apr 18, 2018 | Issued |